Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

RHHBY's higher dose of multiple sclerosis drug Ocrevus did not meet its primary goal when compared to the approved 600 mg dose in relapsing multiple sclerosis patients.

IV therapy delivers hydration, vitamins, and nutrients directly to your bloodstream to boost energy, immunity, and whole-body ...

J.D. Power and Associates recognized Merrillville-based Centier Bank for the first time, giving it the No. 1 ranking in ...

The first time I heard mention of NAD (pronounced “nad” not “N-A-D” by its evangelists) it was from the mouth of Joe Rogan.

UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...

Clostridial myositis, also known as gas gangrene, malignant edema, or clostridial myonecrosis, is an infection of skeletal ...

Details of Trump's "Liberation Day" tariff plans were still being formulated and closely held ahead of a White House Rose Garden announcement ceremony scheduled for 4 p.m. ET. Defaultcategory ...